Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Total Non-Current Liabilities (2023 - 2025)

Adagio Medical Holdings (ADGM) has disclosed Total Non-Current Liabilities for 3 consecutive years, with $30.7 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities changed N/A to $30.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.7 million through Dec 2025, changed N/A year-over-year, with the annual reading at $30.7 million for FY2025, N/A changed from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $30.7 million at Adagio Medical Holdings, down from $32.4 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $47.4 million in Q4 2023, with the low at $23.6 million in Q2 2025.
  • Average Total Non-Current Liabilities over 3 years is $31.8 million, with a median of $29.8 million recorded in 2025.
  • Peak annual rise in Total Non-Current Liabilities hit 14.92% in 2025, while the deepest fall reached 14.92% in 2025.
  • Over 3 years, Total Non-Current Liabilities stood at $47.4 million in 2023, then tumbled by 40.53% to $28.2 million in 2024, then increased by 9.05% to $30.7 million in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $30.7 million, $32.4 million, and $23.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.